Kymera Therapeutics, Inc. - Common Stock (KYMR)
CUSIP: 501575104
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 80,235,145
- Total 13F shares
- 34,637,185
- Share change
- +8,089,563
- Total reported value
- $2,035,073,191
- Put/Call ratio
- 4.3%
- Price per share
- $58.74
- Number of holders
- 115
- Value change
- +$491,859,746
- Number of buys
- 83
- Number of sells
- 38
Quarterly Holders Quick Answers
What is CUSIP 501575104?
CUSIP 501575104 identifies KYMR - Kymera Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501575104:
Top shareholders of KYMR - Kymera Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ATLAS VENTURE ASSOCIATES X, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,763,012
|
$173,161,222 | — | 11 Aug 2021 | |
| BVF INC/IL |
13F
|
Company |
3.3%
|
2,630,658
|
$127,587,000 | — | 30 Jun 2021 | |
| Redmile Group, LLC |
13F
|
Company |
3.2%
|
2,531,508
|
$122,778,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.1%
|
2,448,517
|
$118,754,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
2.7%
|
2,182,429
|
$105,848,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
2,044,224
|
$99,144,000 | — | 30 Jun 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.4%
|
1,959,211
|
$95,022,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.3%
|
1,844,926
|
$89,479,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
1,336,646
|
$64,827,000 | — | 30 Jun 2021 | |
| Deer IX & Co. Ltd. |
13F
|
Company |
1.5%
|
1,235,308
|
$59,912,000 | — | 30 Jun 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1%
|
827,941
|
$40,155,000 | — | 30 Jun 2021 | |
| AJU IB Investment Co., Ltd. |
13F
|
Company |
0.8%
|
639,059
|
$30,994,000 | — | 30 Jun 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.78%
|
626,527
|
$30,387,000 | — | 30 Jun 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.65%
|
519,416
|
$25,192,000 | — | 30 Jun 2021 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
0.6%
|
479,605
|
$23,261,000 | — | 30 Jun 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.51%
|
410,991
|
$19,933,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
341,542
|
$16,564,000 | — | 30 Jun 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.35%
|
282,039
|
$13,678,893 | — | 30 Jun 2021 | |
| Trustees of Columbia University in the City of New York |
13F
|
Company |
0.35%
|
278,127
|
$13,489,000 | — | 30 Jun 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.32%
|
259,895
|
$12,605,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.32%
|
259,515
|
$12,587,000 | — | 30 Jun 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.31%
|
250,000
|
$12,125,000 | — | 30 Jun 2021 | |
| WASATCH ADVISORS LP |
13F
|
Company |
0.3%
|
239,102
|
$11,596,000 | — | 30 Jun 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.23%
|
186,701
|
$9,055,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.2%
|
164,435
|
$7,975,000 | — | 30 Jun 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.19%
|
150,694
|
$7,309,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.17%
|
136,881
|
$6,639,000 | — | 30 Jun 2021 | |
| Asymmetry Capital Management, L.P. |
13F
|
Company |
0.15%
|
123,363
|
$5,983,000 | — | 30 Jun 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.15%
|
119,761
|
$5,808,000 | — | 30 Jun 2021 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.14%
|
108,578
|
$5,266,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
104,076
|
$5,048,000 | — | 30 Jun 2021 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
0.13%
|
100,600
|
$4,879,000 | — | 30 Jun 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.12%
|
100,000
|
$4,850,000 | — | 30 Jun 2021 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.12%
|
100,000
|
$4,850,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.1%
|
83,465
|
$4,048,000 | — | 30 Jun 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
64,665
|
$3,892,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
80,003
|
$3,881,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
68,580
|
$3,326,000 | — | 30 Jun 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.08%
|
67,600
|
$3,279,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
63,688
|
$3,089,000 | — | 30 Jun 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.08%
|
62,740
|
$3,043,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
62,488
|
$3,030,000 | — | 30 Jun 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.06%
|
51,601
|
$2,503,000 | — | 30 Jun 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.06%
|
48,815
|
$2,368,000 | — | 30 Jun 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
48,460
|
$2,350,000 | — | 30 Jun 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.05%
|
39,855
|
$1,933,000 | — | 30 Jun 2021 | |
| NORGES BANK |
13F
|
Company |
0.05%
|
38,382
|
$1,862,000 | — | 30 Jun 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.05%
|
37,759
|
$1,831,000 | — | 30 Jun 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
37,600
|
$1,824,000 | — | 30 Jun 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.05%
|
37,400
|
$1,814,000 | — | 30 Jun 2021 |
Institutional Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR) as of Q3 2021
As of 30 Sep 2021,
Kymera Therapeutics, Inc. - Common Stock (KYMR) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,637,185 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, Redmile Group, LLC, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, FMR LLC, STATE STREET CORP, and Rock Springs Capital Management LP.
This page lists
115
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
109
Q3 2021 holders
115
Holder diff
6
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.